Home > Insider Trading > Filing (0001239241-13-000010)

Filing Details

Accession Number:: 0001239241-13-000010
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-11-27 16:40:03
Reporting Period:: 2013-11-25

Filing Date:: 2013-11-27
Accepted Time:: 2013-11-27 16:40:03
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1113148	Infinity Pharmaceuticals Inc.	INFI	Pharmaceutical Preparations (2834)	330655706

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1239241	B Anthony Evnin	C/O Venrock 530 Fifth Avenue, 22Nd Floor New York NY 10036		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2013-11-25	23,703	$15.40	270,368	No	4	S	Indirect	By Funds
Common Stock	Disposition	2013-11-26	138,961	$14.72	131,407	No	4	S	Indirect	By Funds
Common Stock	Disposition	2013-11-27	1,200	$14.56	130,207	No	4	S	Indirect	By Funds

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	By Funds
No	4	S	Indirect	By Funds
No	4	S	Indirect	By Funds

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	67,400	Direct

Footnotes

Represents an aggregate of 216,345 shares held by Venrock Associates III, L.P. ("VA3"), 48,614 shares held by Venrock Associates, L.P. ("VA"), and 5,409 shares held by Venrock Entrepreneurs Fund III, L.P. ("VEF3"). Venrock Management III, LLC ("VM3") and VEF Management III, LLC ("VEFM3") are the sole general partners of VA3 and VEF3, respectively, and may be deemed to beneficially own the shares held by VA3 and VEF3, respectively. VM3 and VEFM3 expressly disclaim beneficial ownership over all shares held by VA3 and VEF3, respectively, except to the extent of their indirect pecuniary interests therein. Anthony B. Evnin is a member of VM3 and VEFM3. Dr. Evnin expressly disclaims beneficial ownership over all shares held by VA3, VA, VEF3, VM3 and VEFM3 except to the extent of his indirect pecuniary interest therein.
Represents an aggregate of 105,150 shares held by VA3, 23,628 shares held by VA, and 2,629 shares held by VEF3. VM3 and VEFM3 are the sole general partners of VA3 and VEF3, respectively, and may be deemed to beneficially own the shares held by VA3 and VEF3, respectively. VM3 and VEFM3 expressly disclaim beneficial ownership over all shares held by VA3 and VEF3, respectively, except to the extent of their indirect pecuniary interests therein. Anthony B. Evnin is a member of VM3 and VEFM3. Dr. Evnin expressly disclaims beneficial ownership over all shares held by VA3, VA, VEF3, VM3 and VEFM3 except to the extent of his indirect pecuniary interest therein.
Represents an aggregate of 104,190 shares held by VA3, 23,412 shares held by VA, and 2,605 shares held by VEF3. VM3 and VEFM3 are the sole general partners of VA3 and VEF3, respectively, and may be deemed to beneficially own the shares held by VA3 and VEF3, respectively. VM3 and VEFM3 expressly disclaim beneficial ownership over all shares held by VA3 and VEF3, respectively, except to the extent of their indirect pecuniary interests therein. Anthony B. Evnin is a member of VM3 and VEFM3. Dr. Evnin expressly disclaims beneficial ownership over all shares held by VA3, VA, VEF3, VM3 and VEFM3 except to the extent of his indirect pecuniary interest therein.